Prof. Xiaolei Wang | Biomedical | Best Researcher Award

Posted on by ScienceFather

Prof. Xiaolei Wang | Biomedical | Best Researcher Award

Prof Xiaolei Wang, Nanchang University, China

Professor Xiaolei Wang is a distinguished researcher at Nanchang University, specializing in photo-responsive materials for biomedical applications. Holding a Ph.D. from the Changchun Institute of Applied Chemistry (2009) under Academician Yang Xiurong, he is recognized as a National Talent and a Changjiang Young Scholar. He serves as Dean of Jiluan College and Deputy Director of the National-Local Joint Center for Bioengineering Drugs and Technologies. With over 130 publications in top-tier journals like Advanced Materials and ACS Nano, 42 patents, and multiple prestigious awards, his groundbreaking research bridges academia and industry, driving impactful innovations in nanomedicine. 🚀

Professional Profile:

Scopus

Suitability for Best Researcher Award

Professor Xiaolei Wang is a highly accomplished researcher in photo-responsive materials for biomedical applications. His extensive contributions to nanomedicine, regenerative medicine, and antimicrobial technologies demonstrate a profound impact on both academic research and industry. With 130+ high-impact publications, 42 patents, and leadership roles in prestigious institutions, he has consistently driven innovation and interdisciplinary collaboration. His recognition as a National Talent and Changjiang Young Scholar further cements his influence in the scientific community.

Education & Experience 🎓👨‍🏫

  • 🎓 Ph.D. in Applied Chemistry (2009) – Changchun Institute of Applied Chemistry, under Academician Yang Xiurong
  • 📚 Dean, Jiluan College – Nanchang University
  • 🏥 Deputy Director – National-Local Joint Center for Bioengineering Drugs and Technologies
  • 👨‍🔬 Professor – Nanchang University
  • 📖 Research Collaborator – Chinese PLA General Hospital, First Affiliated Hospital of Nanchang University, and Institute of Biomedical Innovation

Professional Development 🚀

Professor Xiaolei Wang has made pioneering contributions to biomedical applications of photo-responsive materials, leading 16 major research projects and publishing 161 SCI-indexed papers. His collaborative projects with top research institutions focus on advanced wound healing, Helicobacter pylori treatment, and neurobiological enhancements. As a recognized National Talent and Changjiang Young Scholar, he bridges cutting-edge research with industry applications, collaborating with China National Pharmaceutical Group and Guangyuan Group. His work in zinc oxide research has transformed its optical properties for biomedical use, earning accolades like the China Hi-Tech Fair Outstanding Product Award. His innovations continue to drive impactful scientific advancements. 🌟

Research Focus  🔬

Professor Xiaolei Wang’s research revolves around photo-responsive materials in biomedicine, particularly in wound healing, antibacterial therapy, and neurological treatments. His breakthrough studies on light-activated artificial skin have set new standards in regenerative medicine. His work on metal-organic framework-based hydrogen-release platforms for targeted bacterial infections is a pioneering approach in antimicrobial nanotechnology. His photo- and magnetic-responsive nasal delivery systems for mental health treatments are redefining non-invasive therapeutic strategies. With a strong interdisciplinary approach, his research integrates materials science, nanotechnology, and medicine, shaping the future of next-generation biomedical treatments. 🧬✨

Awards & Honors 🏅

  • 🏆 National Hundred, Thousand, and Ten Thousand Talents Project – Recognized as a National Talent
  • 🏅 Changjiang Young Scholar Award – Prestigious academic honor
  • 🏆 First Prize of Natural Science (2012) – Jilin Province
  • 🏅 First Prize of Medical Technology (2021) – Jiangxi Province
  • 🏆 China Hi-Tech Fair Outstanding Product Award – Recognition for innovation
  • 🏅 2024 Outstanding Paper Award – Advanced Sensor and Energy Materials
  • 🏆 42 Patents – Innovations in nanomedicine and materials science

Publication Top Notes:

  • 🦷 Yellow light and ultrasound dual-responsive strontium-doped zinc oxide composites for dental caries prevention and remineralization
  • 🍺 Cold beer-inspired multifunctional nanozyme for ischemic stroke with rapid thrombus clearance and long-lasting hydrogen therapy
  • 🩹 A molybdenum sulfide-based nitric oxide controlled release oral gel for rapid healing of oral mucosal ulcers
  • 🦴 Time-dependent electrical active and ultrasound-responsive calcium titanate implant coating with immunomodulation, osteogenesis, and customized antibacterial activity
  • 🦾 Inflammatory microenvironment regulation and osteogenesis promotion by bone-targeting calcium and magnesium repletion nanoplatform for osteoporosis therapy – 📑 1 citation

 

Ms. Cristea Diana | Pharmaceutical | Best Researcher Award

Posted on by ScienceFather

Ms. Cristea Diana | Pharmaceutical | Best Researcher Award

Ms. Cristea Diana, Politehnica University of Bucharest, Romania

Diana Cristea is a dedicated Quality Control professional with expertise in ensuring product integrity in the pharmaceutical industry. She holds a Bachelor’s and Master’s degree in Medical Engineering and Pharmaceutical & Cosmetic Products from the University Politehnica of Bucharest. Diana has worked as a Quality Control Analyst and Supervisor at Rompharm Company, where she has led quality improvements, managed teams, and conducted training sessions. Her recent research in nanocomposites demonstrates her commitment to advancing pharmaceutical technology. Diana is an emerging leader in the field of quality control, with a focus on continuous improvement and regulatory compliance. 🏆🔬📊

Professional Profile:

Google Scholar

Summary of Suitability

Diana Cristea is an outstanding candidate for the Best Researcher Award due to her exceptional contributions to the pharmaceutical industry, with a focus on quality control, innovative nanotechnology research, and continuous professional development.

Education & Experience

  • Bachelor’s degree in Medical Engineering, University Politehnica of Bucharest (2017–2021) 🎓
  • Master’s degree in Pharmaceutical & Cosmetic Products, University Politehnica of Bucharest (2021–2023) 🎓
  • Quality Control Analyst, Rompharm Company, Otopeni (September 2021–October 2023) 🧪
  • Quality Control Supervisor, Rompharm Company, Otopeni (October 2023–Present) 🧑‍🔬

Professional Development

Diana Cristea is actively advancing her professional qualifications to enhance her expertise. She is currently enrolled in the Qualified Person Program at Carol Davila University of Medicine and Pharmacy, where she is gaining in-depth knowledge of pharmaceutical regulations and practices. Diana is also pursuing an ISO 9001 Certification with TUV Austria, aimed at further improving her skills in quality management systems. These qualifications will support her ability to lead in high-standard pharmaceutical and cosmetic product testing. 📚👩‍🏫🛠️

Research Focus

Diana’s research focuses on pharmaceutical nanotechnology, specifically on the development of micafungin-loaded magnetite–salicylic acid–silica nanocomposites. She investigates methods to improve drug stability and biocompatibility using innovative techniques like vortex-mixing microfluidic systems. Her work has led to the creation of nanocomposites with sustained-release properties, providing potential advancements in drug delivery systems for fungal infections. Diana is passionate about nanomedicine and is committed to contributing to global health by enhancing pharmaceutical formulations. 🔬💊🧬

Awards & Honors

  • ISO 9001 Certification, TUV Austria (2024) 🏅
  • Qualified Person Program, Carol Davila University of Medicine and Pharmacy (2024) 🎓
  • Research Publication, MDPI, Materials Journal (2024) 📝

Publication Top Notes:

Vortex-Mixing Microfluidic Fabrication of Micafungin-Loaded Magnetite–Salicylic Acid–Silica Nanocomposite with Sustained-Release Capacity 🧪💊

 

Assist. Prof. Dr. Mohamed skiba | Pharmaceutics Award | Best Innovation Award

Posted on by ScienceFather

Assist. Prof. Dr. Mohamed skiba | Pharmaceutics Award | Best Innovation Award

Assist. Prof. Dr. Mohamed skiba, University of rouen, France

Dr. Mohamed Skiba, is a French national and a distinguished pharmaceutical scientist. He is a lecturer at the Faculty of Medicine and Pharmacy in Rouen, where he leads the Pharmaceutical Team within the Galenic Group. Dr. Skiba earned his Ph.D. in Pharmaceutical Sciences from the University of Paris XI in 1994 and has been active in pharmaceutical research since 1990, focusing on cyclodextrin and drug vectorization. With over 140 international publications, 80 patents, and numerous contributions to books and congresses, he is a recognized expert in pharmaceutical technology. Dr. Skiba is also an active member of several scientific societies, including the French Society of Chemistry and the French Association of Teachers of Technological Pharmacy. He is fluent in French, English, and Arabic.

Professional Profile:

Orcid

Suitability for Best Innovation Award: Dr. Mohamed SKIBA

Dr. Mohamed Skiba’s extensive work in pharmaceutical sciences, particularly his research in drug formulation and cyclodextrin technologies, positions him as a strong candidate for the Best Innovation Award. His innovations, reflected in his numerous patents and publications, highlight his ability to drive pharmaceutical advancements with real-world applications. His leadership in academic and research institutions further amplifies his impact, making him a deserving recipient of this prestigious award.

🎓Education:

Dr. Mohamed Skiba holds a Ph.D. in Pharmaceutical Sciences, which he earned in 1994 from the University of Paris XI, Southern Paris. His academic journey also includes a Diploma of Thorough Studies in Pharmacotechnology and Biopharmacy (1990) from the University of Paris XI in Châtenay-Malabry. In 1990, he obtained a Diploma in Veterinary Pharmaceuticals from the Faculty of Pharmacy, University of Clermont-Ferrand I. Additionally, Dr. Skiba completed advanced studies in pharmacology and electrophysiology with a Control of Research degree from the University of Poitiers in 1989. He also pursued studies in patent rights at the Faculty of Orsay, University of Paris-South, enriching his expertise in pharmaceutical and intellectual property matters.

🏢Work Experience:

Dr. Mohamed Skiba has been a lecturer at the Faculty of Medicine and Pharmacy, University of Rouen, France, since 1998. In this role, he teaches courses in galenic and industrial galenic pharmacy to both undergraduate and graduate students, while also leading the Pharmaceutical Team within the Galenic Group. His professional experience includes serving as a trainee at the Central Pharmacy of the Hospitals of Paris (PCH) and working as an Associated Attaché in Toxicology and Clinical Pharmacology at the Hospital of Corbeil-Essonnes, further enhancing his expertise in pharmaceutical technology and clinical applications.

🏅Awards & Recognition:

Dr. Mohamed Skiba is a prolific contributor to the field of pharmaceutical technology, holding over 80 patents that highlight his innovative work. He has authored 140 international publications and contributed to 9 book chapters, making significant scholarly impacts. Additionally, Dr. Skiba has presented 71 communications at prestigious scientific congresses, sharing his research and advancements with the global scientific community.

🔬Research Focus:

Dr. Skiba’s research primarily centers on pharmaceutical technology, with a particular focus on cyclodextrin and drug vectorization. His work involves improving drug delivery systems, studying bio-polymeric materials, and developing innovative pharmaceutical formulations. He has been involved in numerous pharmaceutical research projects since 1990, contributing to the advancement of drug delivery and formulation technologies.

Publication Top Notes:

  • Powder Self-Emulsifying Drug Delivery System for Mitotane: In Vitro and In Vivo Evaluation
  • In vitro dissolution of encapsulated or dispersed vitamin E and cholesterol is correlated with preservation of refrigerated ovine sperm
  • Exploring the Therapeutic Potential of Algerian Propolis: GC/MS Profiling, Protective Inclusion Complex, and In Silico Evaluation Against SARS‐CoV‐2 Main Proteases
  • Development of a Novel Cyclodextrin–Chitosan Polymer for an Efficient Removal of Pharmaceutical Contaminants in Aqueous Solution

 

 

Mr. Mehmet Onur Yağır | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Mr. Mehmet Onur Yağır | Pharmacology | Best Researcher Award

Mr. Mehmet Onur Yağır ,Sakarya University,Turkey

Mehmet Onur Yağır is an experienced engineer with a robust background in mechanical and electrical engineering. Currently serving as a Teaching Assistant at Sakarya University and an Assistant Manager at Adapazarı Vocational High School, he brings a wealth of knowledge from his 13-year tenure as Chief of Mechanical R&D at Federal Electric. Mehmet is pursuing a PhD in Manufacturing Engineering at Sakarya University, following his Master’s and Bachelor’s degrees in Mechanical Engineering and Electrical and Electronics Engineering from the same institution. Proficient in Unigraphics and SolidWorks, he also has skills in Pro-Engineer, Catia, Matlab, Proteus, Arduino, FluidSim, Maxwel, and C# programming.

Professional Profile:

Orcid

Suitability for Best Researcher Award:

Mehmet Onur Yağır’s combination of extensive industry experience, robust academic background, and diverse technical skills makes him a compelling candidate for the Best Researcher Award. His achievements in mechanical and electrical engineering, coupled with his commitment to advancing research through his PhD studies, position him as an influential figure in engineering research and development.

🎓Education:

Mehmet Onur Yağır holds a diverse and extensive educational background, all from Sakarya University. He is currently pursuing a PhD in Manufacturing Engineering, a program he began in 2021. Previously, he completed his Master’s Degree in Mechanical Engineering at Sakarya University from September 2007 to October 2015. He also earned dual Bachelor’s Degrees in Mechanical Engineering and Electrical and Electronics Engineering, both from Sakarya University, graduating in June 2006.

🏢Work Experience:

Mehmet Onur Yağır has a distinguished career with significant roles in both academia and industry. Since 2019, he has served as a Teaching Assistant at Sakarya University and as an Assistant Manager at Adapazarı Vocational High School. Prior to these positions, he spent 13 years as the Chief of Mechanical R&D at Federal Electric, where he led critical research and development initiatives from 2006 to 2019.

Publication Top Notes:

Title: Examination of Various Abutment Designs Behavior Depending on Load Using Finite Element Analysis

 

 

Dr. Angela Fabiano | Pharmaceutics Awards | Best Researcher Award

Posted on by ScienceFather

Dr. Angela Fabiano | Pharmaceutics Awards | Best Researcher Award

Dr. Angela Fabiano,University of Pisa,Italy

Angela Fabiano is a senior researcher at the University of Pisa, Department of Pharmacy, specializing in drug delivery systems. She earned her Ph.D. in Science of Drugs and Bioactive Substances in 2016, with a focus on innovative pharmaceutical systems based on chitosan and its derivatives. Her research involves the synthesis, purification, and characterization of chitosan derivatives to enhance solubility and pharmaceutical applications, including nanosystems and hydrogels for drug delivery via ocular and oral routes. In 2020, she achieved the scientific qualification for associate professor and has authored over 30 publications, with around 800 citations.

Professional Profile:

Orcid

Scopus

Suitability for Best Researcher Award:

Angela Fabiano’s innovative research in drug delivery systems, significant academic contributions, and recognized scientific qualifications make her an outstanding candidate for the Best Researcher Award. Her work directly impacts the development of novel pharmaceutical systems, positioning her as a leader in her field.

🎓Education:

Angela Fabiano earned her Ph.D. in Science of Drugs and Bioactive Substances from the University of Pisa in 2016. Her doctoral thesis, titled “Innovative Pharmaceutical Systems Based on Chitosan and Its Derivatives,” focused on developing novel pharmaceutical systems using chitosan and its derivatives. Her research explored the synthesis, purification, and characterization of these derivatives to improve solubility and expand their pharmaceutical applications, particularly in the creation of advanced drug delivery systems. This work laid the foundation for her continued contributions to drug delivery research.

🏢Work Experience:

Angela Fabiano is currently a Senior Researcher at the Department of Pharmacy, University of Pisa. Her research focuses on drug delivery systems, specifically the synthesis, purification, and characterization of chitosan derivatives. She is dedicated to advancing the development of nanosystems and hydrogels for drug delivery through various routes, including ocular and oral. Her work aims to enhance the effectiveness and versatility of pharmaceutical applications, contributing significantly to the field of drug delivery.

🏅Awards & Achievements:

Angela Fabiano is currently a Senior Researcher at the Department of Pharmacy, University of Pisa. Her research focuses on drug delivery systems, including the synthesis, purification, and characterization of chitosan derivatives. She is also involved in the development of advanced nanosystems and hydrogels for drug delivery through ocular and oral routes. In 2020, she achieved scientific qualification for the role of Associate Professor at the University of Pisa. She has authored over 30 publications in journals with medium to high impact factors, and her work has been cited approximately 800 times, underscoring her significant contributions to the field.

Publication Top Notes:

  • Title: Cross-Linked Thiolated Hydroxypropyl-β-Cyclodextrin for Pulmonary Drug Delivery
  • Title: Olive Leaf Extracts from Three Italian Olive Cultivars Exposed to Drought Stress Differentially Protect Cells against Oxidative Stress
  • Title: Betaine- and L-Carnitine-Based Ionic Liquids as Solubilising and Stabilising Agents for the Formulation of Antimicrobial Eye Drops Containing Diacerein
  • Title: Bergamot Essential Oil: A Method for Introducing It in Solid Dosage Forms
  • Title: Thiolated Hydroxypropyl-β-Cyclodextrin: A Potential Multifunctional Excipient for Ocular Drug Delivery

 

 

 

 

Prof. Dr. Yukihiko Sugimoto | Pharmacology Awards | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Yukihiko Sugimoto | Pharmacology Awards | Best Researcher Award

Prof. Dr. Yukihiko Sugimoto,Kumamoto University Graduate School of Pharmaceutical Sciences,Japan

Yukihiko Sugimoto is a distinguished biochemist currently serving as a Professor of Biochemistry at Kumamoto University, Japan. Born on November 20, 1965, in Kyoto, Japan, he earned his Ph.D. from Kyoto University in 1994 with a thesis on prostaglandin E receptors. His research, which spans over three decades, focuses on the biochemical and physiological roles of prostaglandins and their receptors. Professor Sugimoto has been recognized with several prestigious awards, including the Young Scientist Award from both The Japanese Pharmacological Society and The Japanese Biochemical Society. His notable publications include influential papers on the role of prostaglandins in various biological processes and diseases.

Professional Profile:

Scopus

Orcid

Summary of Suitability:

Yukihiko Sugimoto stands out as a strong candidate for the Research for Best Researcher Award due to his substantial contributions to the field of biochemistry and pharmacology. His extensive research portfolio, spanning over three decades, showcases significant advancements in understanding prostaglandin receptors and their implications in various physiological and pathological processes.

🎓Education:

Professor Yukihiko Sugimoto completed his undergraduate studies in Pharmaceutical Sciences at the Faculty of Pharmaceutical Sciences, Kyoto University, from 1984 to 1988. He then pursued a Master’s degree in Pharmaceutical Sciences at the Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, between 1988 and 1990. Following this, he obtained his Ph.D. in 1994 from the same department, with his thesis focusing on “A Study for Structure and Function of Prostaglandin E Receptors,” under the supervision of Professor Atsushi Ichikawa

🏢Work Experience:

Professor Yukihiko Sugimoto began his academic career as an Assistant Professor of Physiological Chemistry at Kyoto University, where he worked from 1992 to 1997. He then advanced to the role of Associate Professor of Physiological Chemistry at the same institution, serving from 1997 to 2009. Since 2009, he has been a Professor of Biochemistry at Kumamoto University, continuing his influential research and contributions to the field.

🏅Awards:

Professor Yukihiko Sugimoto has received notable recognition for his contributions to the field of biochemistry. He was honored with the Young Scientist Award by The Japanese Pharmacological Society in 1999 and again by The Japanese Biochemical Society in 2005. These awards acknowledge his significant research achievements and impact on the scientific community.

Publication Top Notes:

  • “The Concise Guide to PHARMACOLOGY 2023/24: G Protein-Coupled Receptors”
    • Citations: 89
  • “Prostaglandin E2 Receptor Ptger4b Regulates Female-Specific Peptidergic Neurons and Female Sexual Receptivity in Medaka”
    • Citations: 2
  • “Metabolic Regulation in Adipocytes by Prostanoid Receptors”
  • “Effects of an ω3 Fatty Acid-Biased Diet on Luteolysis, Parturition, and Uterine Prostanoid Synthesis in Pregnant Mice”
    • Citations: 1
  • “Amakusamine from a Psammocinia sp. Sponge: Isolation, Synthesis, and SAR Study on the Inhibition of RANKL-Induced Formation of Multinuclear Osteoclasts”
    • Citations: 8

 

 

 

Prof. Franciska Erdo | Drug delivery Award | Best Researcher Award

Posted on by ScienceFather

Prof. Franciska Erdo | Drug delivery Award | Best Researcher Award

Prof. Franciska Erdo , Pázmány Péter Catholic University , Hungary

Franciska Vidáné Dr. Erdő, born on May 28, 1964, in Budapest, is a distinguished full professor and lab head at Pázmány Péter Catholic University, Faculty of Information Technology and Bionics. She holds a PhD in pharmacology from Semmelweis University and has extensive experience in both academic and research institutions, including the University of Tours, Charité Medizinische Universität in Berlin, and the Max-Planck Institute in Cologne. Her research focuses on drug research and development, evidenced by her numerous fellowships and scholarships. She has supervised over 31 graduate students and postdoctoral fellows and has been recognized for her teaching excellence. Dr. Erdő has also contributed significantly to scientific literature and education, particularly in the fields of molecular bionics and biomedical innovation.

Professional Profile:

Orcid

Education:

Franciska Vidáné Dr. Erdő earned her MSc in Pharmacy from Semmelweis University in 1987, graduating with top grades. She continued her education at the same institution, achieving a University Doctor degree in Pharmacology with summa cum laude honors in 1994. In 1997, she completed her PhD in Pharmacology, also with summa cum laude distinction, at Semmelweis University, Faculty of Pharmacy. Most recently, in 2019, she received her habilitation from Pázmány Péter Catholic University, Faculty of Information Technology and Bionics.

Work Experience:

Franciska Vidáné Dr. Erdő has held numerous esteemed positions throughout her career. Since 2024, she has been serving as a Full Professor and Lab Head at Pázmány Péter Catholic University, Faculty of Information Technology and Bionics. Prior to this, from 2019 to 2024, she was an Associate Professor and Lab Head at the same institution. She was also a Guest Researcher at the University of Tours, France, in 2022. From 2014 to 2019, she worked as a Senior Research Fellow and Lab Head at Pázmány Péter Catholic University. Her earlier roles include serving as a Senior Research Fellow and Lab Head at SOLVO Biotechnology from 2007 to 2014, and holding a scientific scholarship at Charité Medizinische Universität in Berlin, Germany, from 2005 to 2006. She also worked as a Senior Research Fellow at IVAX Drug Research Institute from 2003 to 2007 and held a Max Planck Fellowship at the Max-Planck Institute für neurologische Forschung in Cologne, Germany, from 2000 to 2003. Her earlier positions include Senior Research Fellow roles at Sanofi-Synthelabo Chinoin from 1997 to 2000 and Biorex R&D Co. from 1995 to 1997. She began her career as a Research Fellow at the Institute for Drug Research from 1990 to 1995 and as a Junior Research Fellow at the same institute from 1987 to 1990.

Publication Top Notes:

1.Fluid Dynamics Optimization of Microfluidic Diffusion Systems for Assessment of Transdermal Drug Delivery: An Experimental and Simulation Study

  • Journal: Scientia Pharmaceutica
  • Publication Date: June 2024

2. Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations

  • Journal: Pharmaceutics
  • Publication Date: June 2024

3. Transdermal Delivery of α-Aminophosphonates as Semisolid Formulations—An In Vitro-Ex Vivo Study

  • Journal: Pharmaceutics
  • Publication Date: May 2023